scholarly journals Effect of Legumes as Part of a Low Glycemic Index Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus

2012 ◽  
Vol 172 (21) ◽  
pp. 1653 ◽  
Author(s):  
David J. A. Jenkins ◽  
Cyril W. C. Kendall ◽  
Livia S. A. Augustin ◽  
Sandra Mitchell ◽  
Sandhya Sahye-Pudaruth ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Glycemic Control ◽  
Cardiovascular Risk Factors ◽  
Glycemic Index ◽  
Low Glycemic Index

Effect of Pulses as Part of a Low Glycemic Index Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes

2012 ◽  
Vol 36 (5) ◽  
pp. S19 ◽  
Author(s):  
Sandra Mitchell ◽  
Cyril C.W. Kendall ◽  
Livia S.A. Augustin ◽  
Sandhya Sahye-Pudaruth ◽  
Sonia Blanco Meija ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Risk ◽  
Glycemic Control ◽  
Cardiovascular Risk Factors ◽  
Glycemic Index ◽  
Low Glycemic Index

Insulin Therapy, Glycemic Control, and Cardiovascular Risk Factors in Young Latin Americans with Type 2 Diabetes Mellitus

2006 ◽  
Vol 54 (1) ◽  
pp. 20-31 ◽  
Author(s):  
Larissa Avilés-Santa ◽  
Karin Salinas ◽  
Beverley Adams-Huet ◽  
Philip Raskin
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Glycemic Control ◽  
Insulin Therapy ◽  
Cardiovascular Risk Factors ◽  
Latin Americans

Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus

2010 ◽  
Vol 7 (6) ◽  
pp. 593-599 ◽  
Author(s):  
Christian S. Göbl ◽  
Werner Brannath ◽  
Latife Bozkurt ◽  
Ammon Handisurya ◽  
Christian Anderwald ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Glycemic Control ◽  
Cardiovascular Risk Factors ◽  
Older Patients

scholarly journals GLP-1 receptor agonists: evolution and advancement in the treatment of type 2 diabetes mellitus

2021 ◽  
Vol 24 (2) ◽  
pp. 105
Author(s):  
Candido, R.
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Glycemic Control ◽  
Cardiovascular Risk Factors ◽  
Cardiovascular Events ◽  
Receptor Agonists

Type 2 diabetes mellitus is a progressive disease, associated with multiple cardiovascular risk factors (obesity, hypertension, dyslipidemia) and with the development of micro- and macro-vascular complications. Several anti-diabetic drugs commonly used, such as sulfonylureas, thiazolidinediones and insulin induce weight gain and have modest or negative effects on cardiovascular risk factors and cardiovascular events. In this context, the GLP-1 receptor agonists (GLP-1 RA) instead have an important action on glycemic control and β-cell dysfunction, show favorable effects on body weight, hypertension and lipid profile, have a reduced risk of hypoglycemia and more recently have demonstrated clear benefits on major cardiovascular events, cardiovascular mortality and renal damage. In these years it has been an evolution on the role of the GLP-1 RA in the new paradigm of type 2 diabetes. For this reason the GLP-1 RA find place at any moment of the cardiovascular and renal continuum, from the initial one for controlling blood glucose and the different risk factors to the most advanced when cardiovascular damage is already present. The GLP-1 RA therefore represent a key elements in the management of patients with type 2 diabetes at any time in the natural history of the disease both for glycemic control and for the prevention of CV and renal events. KEY WORDS GLP-1 receptor agonists; type 2 diabetes; cardiovascular risk factors; cardiovascular disease; cardiovascular outcome trials.

scholarly journals Erratum to: Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study

2015 ◽  
Vol 26 (5) ◽  
pp. 1029-1029 ◽  
Author(s):  
Scott A. Shikora ◽  
James Toouli ◽  
Miguel F. Herrera ◽  
Bård Kulseng ◽  
Roy Brancatisano ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Glycemic Control ◽  
Cardiovascular Risk Factors ◽  
Nerve Block ◽  
Diabetes Mellitus 2
Sign in / Sign up

Export Citation Format

Share Document